54
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Profiling of engineering hotspots identifies an allosteric CRISPR-Cas9 switch

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The CRISPR-associated protein Cas9 from Streptococcus pyogenes is an RNA-guided DNA endonuclease with widespread utility for genome modification. However, the structural constraints limiting the engineering of Cas9 have not been determined. Here we experimentally profile Cas9 using randomized insertional mutagenesis and delineate hotspots in the structure capable of tolerating insertions of a PDZ domain without disrupting the enzyme’s binding and cleavage functions. Orthogonal domains or combinations of domains can be inserted into the identified sites with minimal functional consequence. To illustrate the utility of the identified sites, we construct an allosterically regulated Cas9 by insertion of the Estrogen Receptor α Ligand Binding Domain. This protein displayed robust, ligand-dependent activation in prokaryotic and eukaryotic cells, establishing a versatile one-component system for inducible and reversible Cas9 activation. Thus, domain insertion profiling facilitates the rapid generation of new Cas9 functionalities and provides useful data for future engineering of Cas9.

          Related collections

          Most cited references20

          • Record: found
          • Abstract: found
          • Article: not found

          Synthetic protein scaffolds provide modular control over metabolic flux.

          Engineered metabolic pathways constructed from enzymes heterologous to the production host often suffer from flux imbalances, as they typically lack the regulatory mechanisms characteristic of natural metabolism. In an attempt to increase the effective concentration of each component of a pathway of interest, we built synthetic protein scaffolds that spatially recruit metabolic enzymes in a designable manner. Scaffolds bearing interaction domains from metazoan signaling proteins specifically accrue pathway enzymes tagged with their cognate peptide ligands. The natural modularity of these domains enabled us to optimize the stoichiometry of three mevalonate biosynthetic enzymes recruited to a synthetic complex and thereby achieve 77-fold improvement in product titer with low enzyme expression and reduced metabolic load. One of the same scaffolds was used to triple the yield of glucaric acid, despite high titers (0.5 g/l) without the synthetic complex. These strategies should prove generalizeable to other metabolic pathways and programmable for fine-tuning pathway flux.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Evolution of the protein repertoire.

            Most proteins have been formed by gene duplication, recombination, and divergence. Proteins of known structure can be matched to about 50% of genome sequences, and these data provide a quantitative description and can suggest hypotheses about the origins of these processes.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Small Molecule-Triggered Cas9 Protein with Improved Genome-Editing Specificity

              Directly modulating the activity of genome-editing proteins has the potential to increase their specificity by reducing activity following target locus modification. We developed Cas9 nucleases that are activated by the presence of a cell-permeable small molecule by inserting an evolved 4-hydroxytamoxifen (4-HT)-responsive intein at specific positions in Cas9. In human cells, conditionally active Cas9s modify target genomic sites with up to 25-fold higher specificity than wild-type Cas9.
                Bookmark

                Author and article information

                Journal
                9604648
                20305
                Nat Biotechnol
                Nat. Biotechnol.
                Nature biotechnology
                1087-0156
                1546-1696
                14 May 2016
                02 May 2016
                June 2016
                02 November 2016
                : 34
                : 6
                : 646-651
                Affiliations
                [1 ]Department of Molecular and Cell Biology, University of California, Berkeley, California, USA
                [2 ]Howard Hughes Medical Institute, University of California, Berkeley, California, USA
                [3 ]Innovative Genomics Initiative, University of California, Berkeley, California, USA
                [4 ]Physical Biosciences Division, Lawrence Berkeley National Laboratory, Berkeley, California, USA
                [5 ]Department of Chemistry, University of California, Berkeley, California, USA
                [6 ]Energy Biosciences Institute, University of California, Berkeley, Berkeley, CA, USA
                Author notes
                [* ]To whom correspondence should be addressed. savage@ 123456berkeley.edu
                Article
                NIHMS766766
                10.1038/nbt.3528
                4900928
                27136077
                1d3cc396-b3fa-440d-8186-a32b14a47413

                Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms

                History
                Categories
                Article

                Biotechnology
                Biotechnology

                Comments

                Comment on this article